# Neuroprotective effects of traditional Chinese medicine formulas in animal models of retinal degenerative diseases: a systematic review and meta-analysis

**Authors:** Yunxi Xu, Qindong Mi, Qi Yong, Chao Xu, Dingmeng Zhao, Chuning Wang, Zhongshan Jiang, Chenghao Yu, Hejiang Ye

PMC · DOI: 10.3389/fphar.2025.1695150 · Frontiers in Pharmacology · 2026-01-07

## TL;DR

This study reviews and analyzes the neuroprotective effects of traditional Chinese medicine formulas in animal models of retinal diseases.

## Contribution

It provides the first systematic review and meta-analysis of TCM formulas for retinal degenerative diseases in animal models.

## Key findings

- Certain TCM formulas modulate neural growth and glial activation by affecting biomarkers like BDNF and GFAP.
- Some formulas reduce oxidative stress and apoptosis by lowering SOD and caspase-3 levels.
- Bu-Yang-Huan-Wu decoction improves retinal function by increasing ERG wave amplitudes.

## Abstract

Retinal degenerative diseases (RDDs) cause irreversible vision loss with limited treatment options. Traditional Chinese medicine (TCM) formulas have demonstrated neuroprotective effects, yet their overall efficacy lacks comprehensive meta-evidence. The aim of this study was to exploratively evaluate the neuroprotective effects of TCM formulas in animal RDD models.

A comprehensive literature search was conducted across eight electronic databases to identify animal studies that evaluated the neuroprotective effects of TCM formulas on RDDs. Pairwise meta-analysis and Bayesian network meta-analysis (NMA) were performed to synthesize evidence on key outcomes: neural growth, glial activation, oxidative stress, apoptosis factors, and ophthalmological parameters. Treatment rankings were assessed using the surface under the cumulative ranking curve (SUCRA).

Twenty-four studies were included. The compositions and bioactive compounds of the TCM formulas have been defined and identified. Pairwise meta-analysis demonstrated that specific TCM formulas might exert neuroprotective effects on RDDs by regulating key biomarkers. Specifically, Zhen-Bao-Wan, Bu-Shen-Yi-Jing-Fang, and Qi-Shen-Yi-Qi pills modulated neural growth and glial activation by upregulating BDNF, CNTF, and reducing GFAP, respectively. Furthermore, Yi-Qi-Wen-Yang-Tong-Luo decoction, Zi-Yin-Ming-Mu decoction, and Yishi-Tablet suppressed oxidative stress and apoptosis by reducing SOD, retinal apoptotic cells and caspase-3, respectively. Additionally, Bu-Yang-Huan-Wu decoction improved retinal function by elevating ERG-a and ERG-b wave amplitudes. Subgroup analyses indicated that Bu-Yang-Huan-Wu decoction and Qu-Yu-Tong-Luo prescription exhibited superior efficacy in restoring retinal ganglion cell (RGC) counts and retinal thickness in specific RDD models. The NMA results indicated that the included TCM formulas exhibited target-specific and dose‒response trends, with different formulas showing preferential efficacy for distinct biomarkers. Given the limitations identified in this study, these findings should be interpreted as preliminary evidence to guide future research rather than as conclusive results. Future studies with rigorous experimental designs are needed to address these limitations and enhance translational relevance.

This study provides preclinical and exploratory evidence that the included TCM formulas might exert neuroprotective effects on animal models of RDDs by modulating glial activation, promoting neuronal growth, and inhibiting oxidative stress and apoptosis. Additional high-quality preclinical studies are essential to validate these effects and inform future clinical translation.

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251002491 identifier CRD420251002491.

The graphical abstract was created by using BioGDP.com (Jiang et al., 2025), and no copyright issues are involved.Graphic illustrating the neuroprotective effects of traditional Chinese medicine formulas on retinal degenerative diseases. It shows intervention measures leading to neuroprotection effects, such as neural growth, glial activation, reduction of oxidative stress, and apoptosis. It highlights the impact on retinal structure and function, including ganglion cells and retinal thickness, with reference to ERG-a and b measurements.

The graphical abstract was created by using BioGDP.com (Jiang et al., 2025), and no copyright issues are involved.

## Linked entities

- **Proteins:** BDNF (brain derived neurotrophic factor), CNTF (ciliary neurotrophic factor), GFAP (glial fibrillary acidic protein), SOD1 (superoxide dismutase 1), Casp3 (caspase 3)

## Full-text entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, CNTF (ciliary neurotrophic factor) [NCBI Gene 1270] {aka HCNTF}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}
- **Diseases:** vision loss (MESH:D014786), RDDs (MESH:D012164)
- **Chemicals:** Bu- (MESH:D002066)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819594/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819594/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819594/full.md

---
Source: https://tomesphere.com/paper/PMC12819594